ARTICLE | Company News
Brain Factory, Eisai deal
October 11, 2010 7:00 AM UTC
Eisai granted Brain Factory exclusive rights to develop and commercialize E1224 in Japan to treat fungal infections, excluding Chagas disease. Brain Factory plans to start Phase I testing of the prod...